Disclosed positions
| TALEN ENERGY CORP | TLN | COM | $1,384,170,228 | 3,602,171 | SH | None |
| FTAI AVIATION LTD | FTAI | SHS | $811,590,000 | 3,000,000 | SH | None |
| VIATRIS INC | VTRS | COM | $542,599,639 | 34,168,743 | SH | None |
| TEVA PHARMACEUTICAL INDS LTD | TEVA | SPONSORED ADS | $527,681,000 | 15,575,000 | SH | None |
| GOLAR LNG LTD | GLNG | SHS | $457,480,264 | 9,178,978 | SH | None |
| VISTRA CORP | VST | COM | $284,733,394 | 1,794,953 | SH | None |
| TRANSALTA CORP | TAC | COM | $279,808,712 | 20,232,011 | SH | None |
| FLUOR CORP | FLR | COM | $262,853,623 | 5,017,248 | SH | None |
| KINIKSA PHARMACEUTICALS INTL | KNSA | ORD SHS CL A | $255,787,210 | 3,999,800 | SH | None |
| BGC GROUP INC | BGC | CL A | $254,422,000 | 23,800,000 | SH | None |
| ZOOM COMMUNICATIONS INC | ZM | CL A | $238,734,237 | 2,766,009 | SH | None |
| GILDAN ACTIVEWEAR INC | GIL | COM | $232,200,000 | 4,500,000 | SH | None |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | COM | $216,880,749 | 8,271,577 | SH | None |
| AMAZON COM INC | AMZN | COM | $214,506,000 | 900,000 | SH | None |
| ROIVANT SCIENCES LTD | ROIV | SHS | $212,340,000 | 6,000,000 | SH | None |
| ZYMEWORKS INC | ZYME | COM | $182,980,000 | 7,000,000 | SH | None |
| AMCOR PLC | AMCR | COM NEW | $180,424,001 | 4,162,030 | SH | None |
| CIMPRESS PLC | CMPR | SHS EURO | $177,975,000 | 1,750,000 | SH | None |
| AMNEAL PHARMACEUTICALS INC | AMRX | COM STK CL A | $176,019,505 | 10,168,660 | SH | None |
| NURIX THERAPEUTICS INC | NRIX | COM | $175,345,894 | 7,227,778 | SH | None |
| MERCURY GENL CORP NEW | MCY | COM | $164,348,333 | 1,541,440 | SH | None |
| PENNYMAC FINL SVCS INC NEW | PFSI | COM | $148,070,000 | 1,700,000 | SH | None |
| INTEGRA LIFESCIENCES HLDGS C | IART | COM NEW | $139,260,655 | 7,753,934 | SH | None |
| DELEK US HLDGS INC NEW | DK | COM | $136,549,284 | 2,687,449 | SH | None |
| LIBERTY GLOBAL LTD | LBTYA | COM CL A | $133,629,961 | 11,752,855 | SH | None |
| MEIRAGTX HLDGS PLC | MGTX | COM | $122,941,000 | 9,100,000 | SH | None |
| GEO GROUP INC | GEO | COM | $122,077,521 | 4,131,219 | SH | None |
| LIBERTY LATIN AMERICA LTD | LILAK | COM CL C | $121,877,900 | 15,645,430 | SH | None |
| SCHRODINGER INC | SDGR | COM | $104,000,000 | 6,400,000 | SH | None |
| ECOVYST INC | ECVT | COM | $102,238,006 | 8,211,888 | SH | None |
| LIBERTY GLOBAL LTD | LBTYK | COM CL C | $101,852,971 | 9,259,361 | SH | None |
| COMPASS INC | COMP | CL A | $101,332,798 | 8,218,394 | SH | None |
| NEWELL BRANDS INC | NWL | COM | $98,240,000 | 16,000,000 | SH | None |
| EDGEWELL PERSONAL CARE CO | EPC | COM | $95,204,330 | 3,544,465 | SH | None |
| CORECIVIC INC | CXW | COM | $86,505,106 | 2,847,436 | SH | None |
| ARDELYX INC | ARDX | COM | $82,633,770 | 16,202,700 | SH | None |
| ENOVIS CORPORATION | ENOV | COM | $80,730,000 | 3,900,000 | SH | None |
| ADMA BIOLOGICS INC | ADMA | COM | $78,170,895 | 9,339,414 | SH | None |
| MANNKIND CORP | MNKD | COM NEW | $76,680,000 | 18,000,000 | SH | None |
| DRIVEN BRANDS HLDGS INC | DRVN | COM | $73,890,545 | 5,300,613 | SH | None |
| OPKO HEALTH INC | OPK | COM | $71,686,865 | 47,791,243 | SH | None |
| MISSION PRODUCE INC | AVO | COM | $70,527,226 | 5,981,953 | SH | None |
| ADEIA INC | ADEA | COM | $70,030,025 | 2,126,633 | SH | None |
| RENEW ENERGY GLOBAL PLC | RNW | CL A SHS | $68,750,000 | 11,000,000 | SH | None |
| STRATASYS LTD | SSYS | SHS | $68,480,000 | 8,000,000 | SH | None |
| ARS PHARMACEUTICALS INC | SPRY | COM | $68,412,297 | 8,540,861 | SH | None |
| ANDERSONS INC | ANDE | COM | $68,369,836 | 999,559 | SH | None |
| PRIMO BRANDS CORPORATION | PRMB | CLASS A COM SHS | $65,309,326 | 2,672,231 | SH | None |
| SONOCO PRODS CO | SON | COM | $64,439,719 | 1,143,562 | SH | None |
| STUBHUB HLDGS INC | STUB | CL A | $64,350,000 | 5,000,000 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 1 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.